(CLOZ) Panagram Bbb-B Clo - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81752T5285 • Bank Loan
CLOZ: Collateralized, Loan, Obligations, Rated, Securities
The Panagram Bbb-B Clo ETF (NYSE ARCA:CLOZ) is an actively managed exchange-traded fund designed to capitalize on the opportunities in the market for collateralized loan obligations (CLOs). CLOs are structured financial products that pool together leveraged loans, typically to corporations with lower credit ratings. These loans are then divided into tranches, or slices, with varying levels of risk and return. The fund specifically targets CLOs rated between BBB+ and B-, which places them in the lower rungs of investment grade or upper tier of high-yield debt.
For investors, CLOs offer an attractive risk-return profile. They are senior secured instruments, meaning they have priority over other forms of debt in the event of default. Additionally, CLOs are floating-rate instruments, which makes them less sensitive to interest rate changes compared to traditional fixed-rate bonds. This feature can be particularly appealing in rising interest rate environments. The funds focus on the BBB+ to B- range allows it to balance risk and return, targeting higher yields than investment-grade debt without venturing into the more volatile territory of deeply subordinated or distressed debt.
Active management plays a crucial role in this fund. The managers employ a rigorous selection process to identify CLOs with strong underlying collateral, favorable structural protections, and attractive relative value. This involves analyzing the quality of the loans in the CLO portfolio, the experience of the CLO manager, and the specific terms of the tranche being purchased. Active management is particularly important in the CLO market, where the complexity and heterogeneity of the instruments require deep expertise to navigate effectively.
Its worth noting that this fund is non-diversified, meaning it can take larger positions in individual CLO tranches than a diversified fund might. While this can lead to higher returns if the selected CLOs perform well, it also increases concentration risk. Investors should be aware of this trade-off and consider their own risk tolerance before allocating to the fund.
From a broader market perspective, CLOs have become an increasingly important part of the fixed-income landscape. They provide a way for investors to gain exposure to leveraged loans without directly holding the loans themselves. The CLO market has grown significantly over the past decade, driven by demand for yield in a low-interest-rate world and the relative stability of CLO structures compared to other forms of structured credit.
For fund managers and investors evaluating this ETF, its important to consider the current state of the credit cycle. CLOs tend to perform well during periods of economic growth when defaults are low, but they can face challenges during downturns when loan defaults increase. The funds focus on higher-quality CLO tranches (BBB+ to B-) may provide some buffer against defaults, but no investment in the credit markets is without risk. As with any investment, a thorough understanding of the underlying assets, the management team, and the market environment is essential.
Additional Sources for CLOZ ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLOZ ETF Overview
Market Cap in USD | 999m |
Category | Bank Loan |
TER | 0.51% |
IPO / Inception | 2023-01-23 |
CLOZ ETF Ratings
Growth 5y | 42.0% |
Fundamental | - |
Dividend | 62.1% |
Rel. Strength Industry | 11.4 |
Analysts | - |
Fair Price Momentum | 28.34 USD |
Fair Price DCF | - |
CLOZ Dividends
Dividend Yield 12m | 8.29% |
Yield on Cost 5y | 10.49% |
Annual Growth 5y | 2.61% |
Payout Consistency | 100.0% |
CLOZ Growth Ratios
Growth Correlation 3m | 85.9% |
Growth Correlation 12m | 99.2% |
Growth Correlation 5y | 99.8% |
CAGR 5y | 12.72% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 2.82 |
Alpha | 5.07 |
Beta | 0.05 |
Volatility | 3.14% |
Current Volume | 3045.8k |
Average Volume 20d | 919.1k |
As of March 12, 2025, the stock is trading at USD 26.75 with a total of 3,045,763 shares traded.
Over the past week, the price has changed by -0.34%, over one month by -0.92%, over three months by +0.97% and over the past year by +9.59%.
Partly, yes. Based on ValueRay Analyses, Panagram Bbb-B Clo (NYSE ARCA:CLOZ) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 42.00 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOZ as of March 2025 is 28.34. This means that CLOZ is currently overvalued and has a potential downside of 5.94%.
Panagram Bbb-B Clo has no consensus analysts rating.
According to ValueRays Forecast Model, CLOZ Panagram Bbb-B Clo will be worth about 30.6 in March 2026. The stock is currently trading at 26.75. This means that the stock has a potential upside of +14.39%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 30.6 | 14.4% |